CytomX Therapeutics, Inc.

203 articles about CytomX Therapeutics, Inc.

• CytomX Therapeutics, Inc. To Present Overview Of Precision Cancer Immunotherapies At The Jefferies Immuno-Oncology Summit

  4/13/2015

• CytomX Therapeutics, Inc. Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., To Board Of Directors

  3/19/2015

• CytomX Therapeutics, Inc. Expands Scientific And Clinical Advisory Boards With Leading Experts In Cancer Immunotherapy And Antibody Drug Conjugates

  3/2/2015

• CytomX Therapeutics, Inc. To Present At Cowen and Company 35th Annual Health Care Conference

  2/26/2015

• Pfizer Leads South San Francisco Biotech CytomX Therapeutics, Inc. to $20 Million Funding Round

  1/6/2015

• CytomX Therapeutics, Inc. Expands Leadership Team With Addition Of Michael Kavanaugh, M.D., As Chief Scientific Officer And Head Of Research And Early Development

  1/5/2015

• South San Francisco's CytomX Therapeutics, Inc. Inks Potential $348 Million Cancer-Fighting Deal With Bristol-Myers Squibb Company

  5/28/2014

• CytomX Therapeutics, Inc. To Present Data From Anti-Jagged Probody Program At Upcoming American Association for Cancer Research Annual Meeting 2014

  3/26/2014

• CytomX Therapeutics, Inc. and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets

  1/9/2014

• CytomX Therapeutics, Inc. Presents Data for First-in-Class Jagged Probody™ Program at American Association for Cancer Research-American Association for Cancer Research-EORTC International Conference

  10/23/2013

• CytomX Therapeutics, Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum

  10/1/2013

• CytomX Therapeutics, Inc.Announces Appointment of Krishna Polu, M.D., as Chief Medical Officer; Promotion of Debanjan Ray, MBA, to Vice President, Business Development

  7/16/2013

• Pfizer Inc., SF-Based CytomX Therapeutics, Inc. Ink $635 Million Oncology Deal

  6/7/2013

• CytomX Therapeutics, Inc. Named a 2013 Red Herring Top 100 North America Tech Startup

  6/3/2013

• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan Partners Joins Syndicate

  7/31/2012

• CytomX Therapeutics, Inc. Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors

  3/6/2012

• CytomX Therapeutics, Inc. Seeks to One-Up Eli Lilly and Company, Amgen Cancer Drugs

  3/2/2012

• CytomX Therapeutics, Inc. Promotes Henry Lowman, Ph.D., to Chief Scientific Officer

  10/6/2011

• CytomX Therapeutics, Inc. Announces Appointment of Sean McCarthy as Chief Executive Officer

  8/11/2011

• CytomX Therapeutics Appoints Sean McCarthy as Chief Business Officer

  1/5/2011